Aspen Product Detail for Evista.
| Brand Name: | Evista |
| Generic Name: | Raloxifene hydrochloride |
| Main Indication: | Selective oestrogen receptor modulator. Osteoporosis prevention, treatment in postmenopausal women; invasive breast cancer risk reduction in postmenopausal women at high risk (see full PI) or with osteoporosis |
| Disease Group: | Endocrinology |
| Prescription Status: | Prescription |
| CMI Link: | Click Here for Consumer Medicine Information |
If you have any further questions regarding Evista, please contact us on the telephone or by using the form available here.